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Summary  1 
Aging is a multifactorial process where deterioration of body functions is driven by 2 
stochastic damage while counteracted by distinct genetically encoded repair 3 
systems. In order to better understand the genetic component of aging, many studies 4 
have addressed the gene and protein expression profiles of various aging model 5 
systems engaging different organisms from yeast to human. The recently identified 6 
small non-coding miRNAs are potent post-transcriptional regulators that can modify 7 
the expression of up to several hundred target genes per single miRNA, similar to 8 
transcription factors. Increasing evidence shows that miRNAs contribute to the 9 
regulation of most if not all important physiological processes, including aging. 10 
However, so far the contribution of miRNAs to age-related and senescence-related 11 
changes in gene expression remains elusive. To address this question, we have 12 
selected 4 replicative cell aging models including endothelial cells, replicated CD8+ T 13 
cells, renal proximal tubular epithelial cells, and skin fibroblasts. Further included 14 
were three organismal aging models including foreskin, mesenchymal stem cells and 15 
CD8+ T cell populations from old and young donors. Using LNA-based miRNA 16 
microarrays we identified four commonly regulated miRNAs, miR-17 down-regulated 17 
in all 7, miR-19b and miR-20a, down-regulated in 6 models and miR-106a down-18 
regulated in 5 models. Decrease in these miRNAs correlated with increased 19 
transcript levels of some established target genes, especially the cdk inhibitor 20 
p21/CDKN1A. These results establish miRNAs as novel markers of cell aging in 21 
humans. 22 
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Short take 1 
Continuous stochastic damage contributes to the gradual attenuation of physiologic 2 
functions, which are partially alleviated by genetically encoded repair systems 3 
(Kirkwood, 2008). Genetic determinants which have a direct impact on these 4 
biological processes can be characterized by either studying model organisms that 5 
are amenable to genetic manipulations (Lepperdinger et al., 2008), or by applying 6 
functional genomic methods. Both strategies have helped to identify genes and 7 
proteins which potentially modulate the aging process. Proteins identified in various 8 
studies have been compiled in a database only recently (de Magalhaes et al., 2009). 9 
Yet, hardly any study has so far addressed the role of miRNAs during aging (Bates et 10 
al., 2009; Grillari & Grillari-Voglauer, in press). 11 
MiRNAs are a class of small non-coding silencing RNAs of approximately 22 12 
nucleotides in length (Ghildiyal & Zamore, 2009). They confer specificity to the RNA 13 
induced silencing complex that either degrades or translationally represses target 14 
mRNAs (Bhattacharyya et al., 2006; Carthew & Sontheimer, 2009). Since the 15 
recognition of target mRNAs mainly depends on the small seed region within the 16 
mature miRNA, a single miRNA potentially regulates up to several hundred mRNA 17 
targets, thus orchestrating a large variety of cellular processes (Lim et al., 2005; 18 
Stefani & Slack, 2008). 19 
Here, we have set out to systematically compare miRNA transcription profiles in old 20 
versus young human cells. Employed were in vitro replicative senescence of 21 
endothelial cells (Chang et al., 2005; Hampel et al., 2006), renal proximal tubular 22 
epithelial cells (Wieser et al., 2008), skin fibroblasts (Hutter et al., 2002; Stockl et al., 23 
2006) as well as an intra-individual comparison of in vivo replicatively exhausted 24 
CD8+ T cells (Saurwein-Teissl et al., 2002; Effros et al., 2005). Furthermore, we used 25 
bone-derived mesenchymal stem cells (Fehrer et al., 2007; Laschober et al., 2009), 26 
foreskin (Oender et al., 2008), as well as CD8+ CD28+ T cells from young versus old 27 
donors (Lazuardi et al., 2009). Detailed characterization of these models as well as 28 
an overview over biological and technical replicates and experimental design is 29 
presented in the supplements (Fig. S1 and Fig. S2A). Experiments were approved by 30 
the local ethical committees and written informed consent is available from all 31 
donors. 32 
LNA-miRNA microarrays were spotted (Castoldi et al., 2006) using Sanger miRBase 33 
v9.2 (Griffiths-Jones et al., 2008) probe sets consisting of 559 human, 170 mouse 34 
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and 77 not yet annotated (miRPlus sequences, Exiqon Inc.) miRNA probes. 1 
Microarray design, a comprehensive set of related protocols as well as raw and 2 
normalized intensity data have been submitted to Array Express Database compliant 3 
to MIAME standards (Brazma et al., 2001; Brazma, 2009). For Array Express 4 
accession numbers and detailed materials and methods see supplementary 5 
information and Fig. S2A. 6 
Depending on the experimental system, statistical analysis identified 10-20% of the 7 
miRNAs as regulated, while the majority remained unchanged during aging (Table 8 
S1). Applying hierarchical clustering of all regulated miRNAs, members of the miR-9 
17-92 cluster and paralogous clusters stood out as being commonly down-regulated 10 
(Fig. S3). 11 
Using linear models and moderated T-statistics (Smyth, 2004) in combination with 12 
false-discovery-rate (FDR) adjustment according to Benjamini-Hochberg, we 13 
calculated differential expression of miRNAs (FDR-adjusted p-value < 0.05) for each 14 
of the 7 model systems independ ntly (available as tab-delimited sheet in Table S2). 15 
Intersections of these lists of regulated miRNAs were then analyzed for the 16 
replicative aging models and the ex vivo models which resulted in 5 miRNAs with 17 
common expression changes in replicative aging and 34 miRNAs that changed 18 
expression during organismal aging (Fig 1A). Interestingly, both replicative and 19 
organismal aging, share a common set of 4 miRNAs (“public miRNAs”) that belong to 20 
the miR-17-92 cluster or its paralogous cluster miR-106a-363 and are down-21 
regulated in both conditions (Fig. 1B). Fig. 1B shows that microarray analysis 22 
identified miR-17 as significantly down-regulated in all 7 model systems, while miR-23 
19b, and miR-20a are down-regulated in 6 and miR-106a in 5 out of the 7 model 24 
systems. Interestingly, 3 out of these four miRNAs also share the same seed 25 
sequence (Fig. 1C) indicating a cooperative relief of translational inhibition of a 26 
common and important set of target genes. Although low transcription levels of 27 
mature miR-17 have been found in S-phase cells compared to G0/G1 and G2/M 28 
phase HeLa cells (Cloonan et al., 2008), our result is not a mere growth arrest 29 
phenomenon, since miR-17 and miR-19b are not regulated in young replicating 30 
versus quiescent endothelial cells (data not shown). 31 
Using quantitative PCR we confirmed the down-regulation of miR-17, miR-19b, miR-32 
20a and miR-106a (Fig. 2A) but observed a greater dynamic range in fold changes 33 
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ranging up to a 6-fold down-regulation, thus indicating an even stronger decrease in 1 
the transcription of all four miRNAs with age. 2 
Down-regulation of members of the miR-17-92 cluster has been reported recently in 3 
aging related conditions like in stress induced senescence (G. Li et al., 2009), after 4 
p53 induction (Brosh et al., 2008) as well as after low level irradiation (Maes, An, 5 
Sarojini, Wu et al., 2008) of human fibroblasts. 6 
However, other reports on differential expression of miRNAs in replicative 7 
senescence of fibroblasts (Brosh et al., 2008; Lal et al., 2008; Bhaumik et al., 2009; 8 
Maes et al., 2009), in senescence of mesenchymal stem cells (Wagner et al., 2008), 9 
of human and mouse brain tissue (Lukiw, 2007; N. Li et al., 2009) as well as of 10 
murine liver (Maes, An, Sarojini and Wang, 2008) and lung (Williams et al., 2007; 11 
Izzotti et al., 2009) do not not explicitly report regulation of miR-17-92 miRNAs. This 12 
might either be due to the fact that in some studies only up-regulated miRNAs have 13 
been reported or to the strategy, that only at least 2-fold changed miRNAs were 14 
considered. 15 
Since the ability of array platforms to detect fold changes down to 1.3 fold 16 
(Wurmbach et al., 2003) and since LNA based microarray methodology is considered 17 
to be one of the most sensitive and reliable at the moment (Willenbrock et al., 2009), 18 
we included miR-17-92 cluster members that are significantly regulated even at 19 
levels below 2-fold, even more so, since array results also are reported to have the 20 
tendency to under-estimate the ratios (Wurmbach et al., 2003).  21 
Interestingly, among the published targets of the miR-17-92 cluster is p21/CDKN1A 22 
mRNA (Ivanovska et al., 2008; Inomata et al., 2009). Indeed, p21/CDKN1A mRNA 23 
levels are negatively correlated in all model systems (Fig. 2B), although the ratio in 24 
old versus young T-cells does not reach significance. 25 
These data indicate that the miR-17-92 cluster, which is known to contribute to 26 
transcriptional regulation in cell cycle control and tumorigenesis (He et al., 2005), 27 
also contributes to transcriptional regulation in senescence and aging, consistent with 28 
the known interdependence between senescence and tumorigenesis (Campisi, 2003; 29 
Rodier et al., 2007).  30 
Among others, E2F transcriptionally activates (Woods et al., 2007) and p53 31 
represses the miR-17-92 cluster (Yan et al., 2009). Thus decreased miR-17-92 levels 32 
are consistent with the notion that, E2F family members decrease (Dimri et al., 33 
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1994), while p53 activity increases in senescence (Atadja et al., 1995; Kulju & 1 
Lehman, 1995). 2 
Downstream of miR-17-92 are 19 experimentally confirmed mRNA targets besides 3 
p21. Many of them are involved in tumorigenesis and cell cycle control (Tab. S3). 4 
Indeed, miR-17-92 suppression induces growth arrest in anaplastic thyroid cancer 5 
cell models (Takakura et al., 2008). Furthermore, an increase in the level of miR-17-6 
92 is associated with a decrease of ROS and DNA damage in RB mutated tumor 7 
cells (Ebi et al., 2009). It will be exciting to test in an experimental system whether a 8 
decrease of miR-17-92, as detected in our models of aging, conversely results in 9 
more ROS and DNA damage, both well accepted driving forces of age-related 10 
functional decline.  11 
In summary, our results implicate specific changes of miRNA abundance and activity 12 
in a broad range of human aging models and suggest the use of miR-17 and 19b as 13 
novel biomarkers of cellular aging. 14 
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Figure legends 1 
 2 
Figure 1: Microarray analysis of differential expression and enrichment of 3 
regulated miRNAs in replicative and organismal aging. (a) Size-adjusted Venn 4 
diagram depicting the intersection of regulated miRNAs from replicative and 5 
organismal aging models: the upper, yellow circle represents 5 miRNAs that were 6 
found significantly regulated (false discovery rate adjusted p-value < 0.05) in at least 7 
3 out of the 4 replicative models. Only miRNAs with uniform up- or down-regulation in 8 
all models were considered. For organismal aging experiments 34 miRNAs were 9 
significantly regulated (FDR adjusted p-value < 0.05) in at least 2 out of 3 models, 10 
indicated by the lower, purple circle. (b) The intersection contains three miRNAs of 11 
the miR-17-92 cluster, namely miR-17, miR-19b and miR-20a, as well as miR-106a 12 
of the paralogous miR-106a-363 cluster. The individual “old versus young” ratios for 13 
these miRNAs, calculated from microarray data, are depicted in a barchart. (c) Fold 14 
changes in transcription of young versus old based on microarrays are given for all 15 
members of the miR-17-92 cluster as well as selected miRNAs from paralogous 16 
clusters together with 5’ seed sequences. Adjusted p-values < 0.05 are marked in 17 
bold and underlined format, indicating statistically significant regulation. 18 
 19 
Figure 2: Quantitative real-time PCR of miRNAs and the published target 20 
p21/CDKN1A. (a) Down-regulation of miR-17, miR-19b, miR-20a and miR-106a in 21 
microarray experiments was validated by quantitative PCR analysis. miRNA 22 
expression values were normalized to GAPDH levels for each experiment (n=8; 23 
p<0.05, one sample t-test with µ0 = 0) (b) Messenger RNA levels of p21/CDKN1A 24 
were analysed by qPCR, and normalized to GAPDH expression levels (n=8; p<0.05, 25 
one sample t-test with µ0 = 0). Increased p21 levels were observed in senescence 26 
and organismal aging indicating negative correlation to transcription of members of 27 
the miR-17-92 cluster. 28 
HDF: human diploid fibroblasts, HUVEC: human umbilical vein endothelial cells, 29 
RPTEC: renal proximal tubular epithelial cells, MSC: bone marrow derived 30 
mesenchymal stem cells, FSK: human foreskin, GAPDH: Glycerinaldehyd-3-31 
phosphat-Dehydrogenase. 32 
 33 
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Figure S1: Characteristization of the analyzed model systems of aging. 1 
Representative growth curves of HUVECs (a), fibroblasts (b), and RPTECs (c) are 2 
presented, indicating replicative growth arrests at late passages. Senescence at the 3 
time of harvest was confirmed by >95% positive cells after senescence-associated β-4 
galactosidase staining. Furthermore, morphological characteristics were typical for 5 
senescent cells. Representative images of cells are given below the growth curves. 6 
(d) Replicatively exhausted (CD28-) versus non-exhausted CD8+ T cells (CD28+) 7 
were separated after taking blood samples by magnetic-activated cell separation and 8 
identity and purity of the populations was confirmed by flow cytometry using 9 
antibodies against CD28. (e) Donor characteristics regarding the age range, the 10 
mean age for young and old donors as well as the total number (n) of donors for T 11 
cells, mesenchymal stem cell, and foreskin specimens are summarized. 12 
 13 
Figure S2: Experimental design of differential miRNA analysis. (a) Depending on 14 
the individual experimental setup (the number of biological replicates and the 15 
contrasts that were of interest) an appropriate hybridization strategy was chosen for 16 
each aging model system. Experimental designs of all hybridizations are depicted 17 
using a visualization scheme introduced by (Knapen et al., 2009). In addition to the 18 
number of biological and dye swap replicates, also the Array Express accession 19 
numbers are given, which allow access to the entire set of raw and normalized 20 
microarray data. (b) According to the chosen design, total RNA was hybridized to 21 
Sanger miRBase v8.0 or v9.2 LNA microarrays and scanned as described in the 22 
supporting material and methods section. (c) For data analysis array spot intensities 23 
were first log2 transformed, background corrected using the normexp algorithm and 24 
lowess normalized using R in combination with LIMMA (Linear Models for Microarray 25 
Data, Bioconductor). A representative graph before and after normalization is shown. 26 
Normalized data were then visualized and clustered using Genesis software from TU 27 
Graz, and tested for differential expression by fitting linear models to the data and 28 
applying moderated t-statistics and false discovery rate adjustment. (d) Data 29 
regarding differential expression of miRNAs were confirmed using LNA qPCR. In 30 
addition, expression of selected mRNA targets of the regulated miRNAs was 31 
measured using SYBR Green qPCR. (e) Comprehensive protocols and data for all 32 
miRNA microarray experiments were submitted to Array Express 33 
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(http://www.ebi.ac.uk/microarray-as/ae/) according to the Minimal Information about 1 
Microarray Data (MIAME) submission guidelines. 2 
 3 
Figure S3: Heatmap visualization and clustering of miRNA expression data. (a) 4 
The fold changes in expression (old versus young) of the miRNAs were log2-5 
transformed and visualized in a heatmap where yellow color indicates up-regulation 6 
in aged or replicated samples, while blue corresponds to down-regulation (maximum 7 
yellow/blue color intensities were manually set to three). Experiments as well as 8 
miRNAs were subjected to hierarchical clustering (complete linkage distance 9 
calculation) indicated by dendrograms. (b) Linked expression view of log2 10 
transformed fold changes in miRNA expression (old vs. young or replicated vs 11 
young) is shown. The pink line, corresponding to the median expression change in 12 
each model, indicates that the majority of miRNAs exhibits no regulation (log2 fold 13 
change = 0). The entire set of miRNAs was filtered for miRNAs with altered 14 
transcription (+/- 0.4 log2-fold change) in the majority of the single model systems 15 
resulting in 17 miRNAs. (c) A heatmap of these 17 miRNAs after hierarchical 16 
clustering is shown. Clustering yielded a 9 miRNAs comprising cluster characterized 17 
by consistent down-regulation in the majority of experiments. miRNAs generated 18 
from a single primary transcript at 13q31.3 – the miR-17-92 cluster of miRNAs – (or 19 
paralogous clusters 106a-363 and 106b-25) were found to be enriched among these 20 
miRNAs and are highlighted by black arrows. 21 
 22 
Table S1: Overview on total numbers of transcribed miRNA as well on miRNAs 23 
detected as differentially transcribed. From a total set of 806 miRNAs, those with 24 
transcription levels 2-fold above background were considered present and subjected 25 
to statistical testing. miRNAs were considered to be differentially transcribed if a false 26 
discovery rate adjusted p-value of below 0.05 was found. 27 
HUVEC: human umbilical vein endothelial cells; HDF: normal human diploid 28 
fibroblasts; RPTEC: renal proximal tubular epithelial cells; MSC: bone marrow 29 
derived mesenchymal stem cells; FSK: human foreskin; RA: replicative aging; OA: 30 
organismal aging 31 
 32 
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Table S2: Compilation of all regulated miRNAs in all experimental systems 1 
(provided as MS Excel file only). Each model system is presented in a separate 2 
excel sheet. 3 
 4 
Table S3: Experimentally validated target mRNAs of the miR-17-92 cluster. 5 
References within the table correspond to following within the main text: 6 
(1) Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, 7 
Gabrielli B, Grimmond SM (2008) The miR-17-5p microRNA is a key regulator 8 
of the G1/S phase cell cycle transition. Genome Biol 9, R127. 9 
(2) Hossain A, Kuo MT, Saunders GF (2006) Mir-17-5p regulates breast cancer cell 10 
proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26, 8191-11 
8201. 12 
(3) Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, 13 
Kobayashi SV, Lim L, Burchard J, Jackson AL, et al. (2008) MicroRNAs in the 14 
miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol 15 
Cell Biol 28, 2167-2174. 16 
(4)  Landais S, Landry S, Legault P, Rassart E (2007) Oncogenic potential of the 17 
miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 18 
67, 5699-5707. 19 
(5)  Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction 20 
of mammalian microRNA targets. Cell 115, 787-798. 21 
(6)  O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-22 
regulated microRNAs modulate E2F1 expression. Nature 435, 839-843. 23 
(7)  Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, 24 
Zanesi N, Alder H, Hagan JP, et al. (2008) MicroRNAs regulate critical genes 25 
associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A 105, 26 
12885-12890. 27 
(8)  Pickering MT, Stadler BM, Kowalik TF (2009) miR-17 and miR-20a temper an 28 
E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 28, 29 
140-145. 30 
(9) Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio 31 
M, Roldo C, Ferracin M, et al. (2006) A microRNA expression signature of 32 
human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103, 33 
2257-2261. 34 
(10) Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, Wu K, Whittle J, Ju X, 35 
Hyslop T, et al. (2008) A cyclin D1/microRNA 17/20 regulatory feedback loop in 36 
control of breast cancer cell proliferation. J Cell Biol 182, 509-517. 37 
(11) Li G, Luna C, Qiu J, Epstein DL, Gonzalez P (2009) Alterations in microRNA 38 
expression in stress-induced cellular senescence. Mech Ageing Dev. 39 
 40 
 41 
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Supporting Material and Methods 1 
 2 
Cell Lines 3 
Human Dermal Fibroblasts (HDFs) 4 
Normal human fibroblasts were isolated from skin biopsies of two different healthy 5 
causcasian patients, a 41-years old female (HDF-1) and a 16-years old male (HDF-6 
5). HDF-5 and HDF-1 cells were cultivated in DMEM/HAM’s F-12 medium (Biochrom 7 
KG, Berlin, Germany) supplemented with 10% fetal calf serum (FCS) 4 mM L-8 
glutamine (Sigma) and Primocin antibiotics (100 µg/mL). Cells were grown at 37 °C 9 
in ambient atmosphere containing 5% CO2. Until confluence was reached HDF cells 10 
were routinely passaged at 1:4 or 1:3 split ratios. Upon decrease in growth rate and 11 
entry of irreversible growth arrest split ratio was changed to 1:2 and after cells had 12 
stopped dividing, fresh medium was added every 7 days. HDF-1 cells reached 13 
senescence after 54 population doublings (PDLs), while HDF-5 cells had stopped 14 
growing after 72.7 PDLs. 15 
 16 
Human Umbilical Vein Endothelial Cells (HUVECs) 17 
Endothelial cells were isolated from human umbilical veins (Jaffe et al., 1973) and 18 
cultured in Endothelial Cell Basal Medium (Lonza) supplemented with EGM Single 19 
Quots (Lonza), containing hEGF 0.5 mL, hydrocortisone 0.5 mL, GA-1000 0.5 mL, 20 
BBE 2.0 mL, FBS 10.0 mL. The cells were subcultured by trypsinization with trypsin-21 
EDTA (Gibco Life Technologies, Vienna, Austria), seeded on cell culture dishes 22 
coated with 0.2% gelatine and grown at 37 °C at ambient atmosphere containing 5% 23 
CO2. Cells were passaged at a ratio of 1:5 in regular intervals. At later passages, the 24 
splitting ratio was reduced to 1:3 and 1:2, respectively. Cells were passaged before 25 
reaching 70-80% confluency. PDL were estimated using the following equation: PDL 26 
= (log10(F)−log10(I)) / 0.301 (where F is the number of cells at the end of one 27 
passage, and I the number of cells that were seeded at the beginning of one 28 
passage). After roughly 50 population doublings, cells had reached growth arrest. 29 
 30 
Renal Proximal Tubular Epithelial Cells (RPTECs) 31 
RPTECs were cultivated as recently reported (Wieser et al., 2008). In brief, within 24 32 
hours after surgery tissue from the renal cortex was fragmented and incubated at 33 
37°C for 15-20 minutes in DMEM/Ham’s F12 (1:1) (Biochrom KG, Berlin, Germany) 34 
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containing 1 mg/mL collagenase type IV (PAN-BioTech GmbH, Aidenbach, 1 
Germany) and 1 mg/mL trypsin-inhibitor (Sigma, Vienna, Austria). After being passed 2 
through a 105 µm nylon mesh the filtrate was centrifuged, washed twice with 3 
phosphate buffered saline (PBS), resuspended in medium and dispensed into roux-4 
flasks (Nunc, Wiesbaden, Germany). 24 hours thereafter medium was changed. The 5 
initial passage of confluent cells after 3-5 days was considered as PDL zero. Cells 6 
were passaged (1:2 to 1:4) at confluence, using 0.25% trypsin/0.02% EDTA, which 7 
was inactivated with 1 mg/mL trypsin-inhibitor. Cumulative PDL was calculated as a 8 
function of passage number and split ratio. Medium consisted of DMEM/Ham’s F12 9 
(1:1) supplemented with 4 mM L-glutamine, 10 mM HEPES buffer, 5 pM 10 
triiodothyronine, 10 ng/mL recombinant human EGF, 3.5 µg/mL ascorbic acid, 5 11 
µg/mL transferrin, 5 µg/mL insulin, 25 ng/mL prostaglandin E1, 25 ng/mL 12 
hydrocortisone and 8.65 ng/mL sodium selenit (all from Sigma). For RPTEC/TERT1 13 
the medium was supplemented with 100 µg/mL G418 (Sigma). 14 
 15 
In vivo specimens 16 
Mesenchymal Stem Cells 17 
MSC were isolated from the iliac crest of systemically healthy individuals (young 18 
donors, n=4, mean age 18, range 5-23; elderly donors, n=4, mean age 66, range 47-19 
78) which had been harvested for reconstructive bone surgery of defects within other 20 
areas of the body as described previously (Fehrer et al., 2007). Briefly, a small 21 
biopsy of substantia spongiosa osseum, which otherwise would have been discarded 22 
based on necessary bone for molding and recontouring prior to insertion into the 23 
recipient site was taken to further investigation under an Institutional Review Board-24 
approved protocol after having obtained patients’ written consent. After surgery, the 25 
bone was transferred into minimal essential medium (MEM) supplemented with 20% 26 
heat-inactivated fetal calf serum, 100 units/mL penicillin, 100 µg/mL streptomycin 27 
(growth medium) for transportation from the operation theatre to the clean room at 28 
room temperature. The biopsies were fragmented and marrow cells were isolated 29 
from pieces (20-100 mm3) by centrifugation (400xg, 1 minute). After centrifugation, 30 
the remaining pieces were treated with collagenase (2.5 mg/mL in MEM) for 2-3 31 
hours at 37°C, 20% O2 and 5% CO2. Thereafter, the specimen was again centrifuged 32 
(400xg, 1 minute). Cells were resuspended and loaded on a Ficoll-Paque Plus® 33 
gradient and centrifuged at 2,500xg for 30 minutes. Cells were harvested from the 34 
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interphase (density <1.075 g/mL), washed and collected by centrifugation (1,500xg, 1 
15 minutes). Cells were cultured at a density of 0.2 – 0.5 x 106 cells/cm2 at 5% CO2 2 
and 37°C and 3% O2 (Thermo Electron Forma Series II, 3110). After 24 hours, the 3 
non-adherent cell fraction was removed by washing twice with phosphate-buffered 4 
saline (PBS). After the primary culture had reached approximately 30 – 50% 5 
confluence, cells were washed twice with PBS, and subsequently treated with 0.05% 6 
trypsin / 1 mM EDTA for 3 – 5 minutes at 37°C. Cells were harvested, washed in 7 
MEM and further expanded at a density of 50 cells/cm². 8 
 9 
T cells 10 
Isolation of CD8+CD28+ and CD8+CD28- T cells from peripheral blood of apparently 11 
healthy young (<35y, n=6, mean age 29, range 26-35) and elderly (>65y, n=10, 12 
mean age 72, range 66-87) donors was performed by preparing peripheral blood 13 
mononuclear cells (PBMCs) by Ficoll-Paque PLUS (Amershan Biosciences) density 14 
gradient centrifugation as approved by the local ethics committee. CD8+ T cells were 15 
negatively selected from the obtained PBMC fraction by applying the magnetic 16 
separation protocol CD8+ T cell isolation kit II (depleting CD4, CD14, CD16, CD19, 17 
CD36, CD56, CD123, TCRγ/δ and CD235a, Miltenyi Biotec) according to the 18 
manufacturer’s instructions. Subsequently, purified CD8+ T cells were stained with an 19 
Allophycocyanin (APC)-conjugated αCD28 monoclonal antibody (mAb) and split into 20 
CD8+CD28+ and CD8+CD28- T cell populations using αAPC MicroBeads (Miltenyi 21 
Biotec) by passing the cell suspension through a positive selection column (LS; 22 
Miltenyi Biotec) mounted in a magnetic field. The CD8+CD28- T cell fraction was then 23 
reincubated with αAPC MicroBeads and run over a fresh LS-column to increase 24 
purity. For phenotypic analysis, purified T cell fractions were labelled with a 25 
combination of mAbs (αTCRαβ-FITC, αCD16-PE, αCD4-PerCP, αCD8-PE-Cy7, 26 
αCD28-APC and αCD3-APC-Cy7; all BD Biosciences - Pharmingen) and analyzed 27 
on a FACSCanto II (BD Biosciences) revealing that the described isolation protocol 28 
yields population homogeneities of >95%. 29 
 30 
Foreskin 31 
Foreskins from donors of different age were frozen in liquid nitrogen and grinded in a 32 
mortar. Each sample was lysed in 2 mL Trizol (Invitrogen), and RNA was prepared 33 
as described below.  34 
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Microarray Analysis of miRNA Expression 1 
RNA Extraction 2 
For two channel microarray analysis of miRNA expression 0.5 to 1 µg of high quality 3 
total RNA were used for labeling. Briefly, total RNA was extracted from cells using 4 
Trizol reagent (Invitrogen, CA). 106 - 5*106 cells were pelleted at 900xg for 10 5 
minutes and homogenized in 1 mL Trizol (Invitrogen) by vigorous mixing on a vortex 6 
(15 sec) followed by incubation at RT for 5 minutes. 200 µL Chloroform were added 7 
per 1 mL Trizol, and mixed on a vortex for 15 seconds followed by 3-minute 8 
incubation at room temperature. Samples were then centrifuged at 12000xg and 4°C 9 
for 15 minutes. The upper (aqueous) phase was transferred to a new RNase-free 10 
tube and precipitated with 0.5 mL isopropanol (100%, room temperature) per 1 mL 11 
initial volume of Trizol. Samples were incubated 10 minutes at room temperature, 12 
followed by centrifugation at 12000xg for 10 minutes (4°C). The supernatant was 13 
discarded and the RNA pellet was washed with 1 mL 75% EtOH (room temperature), 14 
and subsequently centrifuged at 7500xg for 5 minutes. Ethanol was discarded and 15 
the RNA pellet was dried for 10 minutes at room temperature in a fume hood. For 16 
resuspension of RNA pellets 20 µL RNase-free water were used. To increase 17 
solubility resuspended RNA was incubated at 60°C for 10 minutes. RNA 18 
concentration was quantitated using NanoDrop (ThermoScientific, Wilmington, USA) 19 
and quality was assessed by testing ribosomal RNA integrity (RNA 6000 Nano Kit, 20 
Agilent, Germany). RNA with integrity numbers (RIN) equal or greater than 7 were 21 
subsequently stored at -80°C. 22 
 23 
In-house LNA MiRNA Chips (MRC) 24 
MiRNA Microarrays were spotted on epoxy-coated Nexterion glass slides (Schott 25 
AG, Germany) using the MicroGrid II (Zinsser Analytic, Germany) Microarrayer and 26 
miRBase version 8.0 or 9.2 locked nucleic acid probe set (Exiqon Inc., Denmark), 27 
respectively. The spotted probe set consisted of 559 human and 170 murine miRNAs 28 
as well as of 77 miRPlus (intellectual property of Exiqon Inc, Denmark) sequences, 29 
which were spotted in 8 replicates on each array. Spotting was performed according 30 
to the supplier´s instruction manual and recommendations provided by Exiqon. 31 
Subsequently, in order to assure the quality of spotted miRNA microarrays, scanning 32 
of all slides was performed. Weak buffer autofluorescence confirmed the presence of 33 
more than 98% of spots. 34 
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 1 
 2 
 3 
RNA Hybridization 4 
For two channel microarray analysis of miRNA expression 0.5 to 1 µg of high quality 5 
total RNA were used for labelling using the miRCURY LNA miRNA Array labelling kit 6 
(Exiqon, Inc; unless mentioned, all reagents were purchased from Exiqon). Following 7 
calf intestinal phosphatase cleavage for 30 minutes at 37°C, labelling with Cy3 and 8 
Cy5 fluorescent dyes was performed in a PCR thermocycler at 16°C for 1 hour 9 
followed by incubation for 15 minute at 65°C to stop the reaction. Cy3 and Cy5 10 
labelled samples were pooled and mixed with nuclease free water and 2x 11 
hybridization buffer to yield 90 µL of hybridization sample in 1x hybridization buffer. 12 
Prior to hybridization samples were denatured at 95°C for 2 minutes and snap cooled 13 
on ice. RNA samples were then hybridized at 60°C for 16 hours to in-house spotted 14 
LNA miRNA chips using a TECAN HS 400 hybridization station (Tecan, Switzerland). 15 
Following hybridzation, washing and drying of LNA miRNA microarrays, arrays were 16 
immediately scanned using a GenePix 4000B laser scanner and GenePixPro 4.1 17 
software (Axon Instruments). Cy3 dye was scanned at 532nm and Cy5 at 635nm. 18 
Scanning settings were adjusted to 10µM resolution and averaging per 1 line. 19 
Photomultiplier settings were adjusted individually for Cy3 and Cy5 according to the 20 
results from preview scans. 21 
 22 
Microarray data analysis 23 
R/Bioconductor 24 
Intensity values for each spot were extracted using GenePix 4.1 software and 25 
inserted into R. Bioconductor and the “Linear models for microarray data analysis” 26 
package (Smyth, 2004) were used for the calculation of M-A values for each spot, 27 
where M stands for logarithmic red/green ratio (log2[R/G]) and A for average log2 28 
intensity (log2[R*G]*0.5). The MA dataset of each array was background corrected 29 
using normexp algorithm and lowess (local weighted linear regression) normalized. 30 
Normalized data compared to raw data was visualized using MA and PrintTip Boxplot 31 
diagnostic plots as well as density plots (Smyth & Speed, 2003). Subsequently, in 32 
order to calculate fold changes in miRNA expression in replicated or aged samples, 33 
the 8 replicate spots of each miRNA per array were correlated and linear models 34 
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were fitted to the data (Smyth et al., 2005). Contrast matrices were defined 1 
individually for each experiment, and moderated hypothesis tests (moderated t-2 
statistic) were performed for the contrasts of interest. The data was then adjusted for 3 
multiple testing (p-adj.), by controlling the false discovery rate according to a method 4 
of Benjamini and Hochberg. All miRNAs were then ranked in terms of their adjusted 5 
p-values and a cut-off of p-adj. ≤ 0.05 was imposed (Hochberg & Benjamini, 1990). 6 
 7 
Clustering and Visualization of Array Data 8 
In order to cluster and visualize log2-transformed ratios (LFC) in a heatmap, the freely 9 
available Genesis software (Sturn et al., 2002) was used. The LFCs of  347 miRNAs 10 
(corresponding to the intersection between miRBase v8.0 and v9.2 arrays, plus 77 11 
proprietary miRPlus sequences from Exiqon) were inserted in Genesis and, in a 12 
second step, filtered for miRNAs which exhibited log2-fold changes greater than the 13 
average fold change plus 1.5 fold the standard deviation in at least 4 out of 7 14 
experiments (corresponding to a LFC of +/- 0.4). 15 
For identification and visualization of miRNAs regulated in both replicative and 16 
organismal aging, the web-based BioVenn application was used (Hulsen et al., 17 
2008).  18 
 19 
Quantitative miRNA LNA-PCR and mRNA PCR 20 
Isolated total RNA from all samples was brought to a concentration of 10 ng/µL and 2 21 
ng/µL in RNAse-free water and quantitative PCR (qPCR) was performed on selected 22 
miRNAs and on the internal housekeeping gene glyceraldehyde-3-phosphate 23 
dehydrogenase (GAPDH) as well as p21/CDKN1A using a RotorGene 6000 Real-24 
Time Cycler (Qiagen, Germany). 25 
For each miRNA, 9 ng total RNA preparation (4.5 µL) were reverse transcribed in a 26 
LNA first strand cDNA synthesis reaction using the miRCURY LNA miRNA PCR 27 
System (Exiqon, Inc.) in combination with validated LNA PCR primers (Exiqon, Inc.). 28 
Subsequent to 1:10 dilution of the obtained cDNA, 4 µL were used for quadruplicate 29 
miRNA PCR reaction according to recommendations of the manufacturer. For 30 
GAPDH housekeeping gene as well as p21/CDKN1A, 70 ng total RNA were reverse 31 
transcribed using MMLV-reverse transcriptase (Finnzymes, Finnland) and random 32 
hexamer primers. Following 1:3 dilution in nuclease-free water, 1 µL cDNA was 33 
qPCR amplified in quadruplicate using SensiMix Plus SYBR Green (Quantace, 34 
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 24 
Germany) and specific primers (250 pM final concentration).  To ensure appropriate 1 
size of the amplification products, melting points were determined after each 2 
amplification. For copy number determination of mRNAs, internal standards were 3 
included in each run. These were derived from PCR amplification from human cDNA 4 
and subsequent PCR product purification (Promega) and quantitation. Six standards 5 
in the range from 108 to 103 copies/µL were included in each run. The resulting 6 
standard curve was calculated in Rotor-Gene 6000 Series Software 1.7 and used for 7 
quantification of copy numbers of mRNA targets. 8 
 9 
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Exiqon Reporter ID (v9.2) Reporter Name log2 Fold Change
28351 mmu-miR-762 2.886
17890 miRPlus_17890 3.254
21472 miRPlus_21472 2.560
27561 miRPlus_27561 2.594
17558 hsa-miR-663 2.785
13511 hsa-miR-210 1.571
11130 hsa-miR-498 1.507
17399 mmu-miR-501-3p 1.781
5740 hsa-miR-21 1.031
17836 hsa-miR-30b* 1.071
17423 hsa-miR-584 1.766
13180 hsa-miR-483-3p 1.287
17848 miRPlus_17848 -1.237
21757 hsa-miR-766 1.775
17885 hsa-miR-886-5p -1.171
17321 mmu-miR-689 1.258
27692 hsa-miR-886-3p -1.223
17878 hsa-miR-193a-5p 1.094
17413 hsa-miR-565 -1.375
11124 hsa-miR-492 1.210
17559 mmu-miR-715 0.983
17280 hsa-miR-15b -0.995
29872 hsa-miR-340 -0.683
13137 hsa-miR-518e*/519a*/519b-5p/519c-5p/522*/523* 1.111
11023 hsa-miR-222 -0.539
11065 hsa-miR-335 1.300
27720 hsa-miR-15a -0.691
17512 mmu-miR-711 0.538
28232 miRPlus_28232 0.736
4890 hsa-miR-19b -0.587
10967 hsa-miR-16 -0.866
11048 hsa-miR-30a 0.577
17950 hsa-miR-371-5p 0.851
17894 hsa-miR-501-3p 0.593
19580 hsa-let-7i -0.557
28736 hsa-miR-17 -0.473
11020 hsa-miR-22 0.445
11039 hsa-miR-29a 0.450
10986 hsa-miR-193a-3p -0.484
17309 hsa-miR-623 0.722
27560 miRPlus_27560 0.665
11089 hsa-miR-376a -0.471
17903 hsa-miR-940 0.465
28950 hsa-miR-455-3p -0.475
27217 hsa-miR-34a 0.539
11125 hsa-miR-493* -0.502
10964 hsa-miR-155 -0.558
17510 hsa-miR-602 0.979
10999 hsa-miR-20a -0.487
19594 hsa-miR-296-5p 0.526
11030 hsa-miR-26a 0.397
Page 32 of 53
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support: (434) 817 2040 ext. 167
Aging Cell
For Peer Review
Fold Change log2 Average Intensity p-value FDR adjusted p-value
7.390 10.413 4.43E-20 3.57E-17
9.537 10.551 9.03E-19 3.64E-16
5.899 9.984 2.89E-18 7.76E-16
6.039 10.390 9.74E-17 1.96E-14
6.894 8.850 2.21E-16 3.56E-14
2.971 8.920 2.22E-14 2.99E-12
2.842 9.083 7.37E-14 8.49E-12
3.436 10.007 1.53E-13 1.54E-11
2.044 13.715 1.93E-12 1.73E-10
2.101 8.453 2.75E-12 2.22E-10
3.401 9.007 1.40E-11 1.03E-09
2.440 8.676 2.89E-11 1.94E-09
-2.357 9.159 5.46E-11 3.37E-09
3.422 9.065 5.86E-11 3.37E-09
-2.252 9.878 9.71E-11 5.22E-09
2.392 8.434 1.38E-10 6.93E-09
-2.334 10.984 1.66E-10 7.87E-09
2.134 9.401 1.53E-09 6.87E-08
-2.594 8.397 1.32E-08 5.62E-07
2.314 8.460 1.40E-08 5.65E-07
1.976 8.118 3.18E-08 1.22E-06
-1.993 8.817 3.36E-08 1.23E-06
-1.605 9.382 1.38E-07 4.82E-06
2.160 8.022 5.76E-07 1.93E-05
-1.453 11.388 1.97E-06 6.34E-05
2.462 7.188 2.46E-06 7.63E-05
-1.614 9.378 4.22E-06 1.26E-04
1.452 10.904 7.89E-06 2.27E-04
1.666 7.941 1.44E-05 3.99E-04
-1.502 9.245 1.50E-05 4.04E-04
-1.822 9.227 1.64E-05 4.26E-04
1.492 10.047 5.01E-05 1.26E-03
1.804 7.780 6.16E-05 1.51E-03
1.508 8.094 1.14E-04 2.70E-03
-1.472 10.503 2.57E-04 5.92E-03
-1.388 8.332 4.74E-04 1.06E-02
1.362 11.931 6.73E-04 1.47E-02
1.366 12.606 7.11E-04 1.51E-02
-1.399 10.900 8.44E-04 1.74E-02
1.650 7.453 9.68E-04 1.94E-02
1.586 7.814 9.89E-04 1.94E-02
-1.386 8.536 1.01E-03 1.94E-02
1.380 7.935 1.23E-03 2.30E-02
-1.390 7.998 1.25E-03 2.30E-02
1.453 10.333 1.41E-03 2.52E-02
-1.416 8.060 1.61E-03 2.82E-02
-1.472 7.321 1.69E-03 2.85E-02
1.971 7.938 1.70E-03 2.85E-02
-1.401 7.740 2.14E-03 3.52E-02
1.440 8.021 2.76E-03 4.39E-02
1.317 10.869 2.78E-03 4.39E-02
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27565 hsa-miR-423-5p 0.695 1.619 13.224
4890 hsa-miR-19b -0.835 -1.784 11.347
28736 hsa-miR-17 -0.787 -1.725 11.359
28737 hsa-miR-106a -0.658 -1.578 10.987
19581 hsa-miR-100 0.551 1.465 12.008
17521 mmu-miR-714 0.493 1.407 10.837
17869 miRPlus_17869 -0.444 -1.361 11.852
17583 mmu-miR-720 -0.393 -1.313 13.263
17321 mmu-miR-689 0.368 1.291 11.361
19599 mmu-miR-106a -0.611 -1.527 10.110
27898 hsa-miR-768-3p 0.621 1.538 11.138
11078 hsa-miR-365 0.608 1.524 10.939
10967 hsa-miR-16 -0.645 -1.564 10.209
30787 hsa-miR-125b 0.522 1.436 11.641
32883 hsa-miR-801 -0.466 -1.381 11.055
17952 miRPlus_17952 -0.334 -1.260 12.096
27692 hsa-miR-886-3p -0.427 -1.345 13.130
10999 hsa-miR-20a -0.539 -1.453 10.644
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4.41E-08 3.55E-05
2.93E-07 1.18E-04
7.55E-07 1.85E-04
9.42E-06 1.30E-03
9.67E-06 1.30E-03
3.40E-05 3.91E-03
5.30E-05 5.34E-03
1.86E-04 1.56E-02
2.01E-04 1.56E-02
2.14E-04 1.56E-02
2.64E-04 1.77E-02
3.53E-04 2.19E-02
3.81E-04 2.19E-02
7.03E-04 3.78E-02
9.38E-04 4.73E-02
1.02E-03 4.75E-02
1.10E-03 4.75E-02
1.12E-03 4.75E-02
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Exiqon Reporter ID (v8.0) Reporter Name log2 Fold Change Fold Change
10306 hsa-miR-146b 1.961 3.893
10986 hsa-miR-193a -1.014 -2.019
11030 hsa-miR-26a 0.902 1.868
10924 hsa-miR-10a 0.894 1.858
10952 hsa-miR-146a 2.099 4.285
11062 hsa-miR-33 -0.897 -1.863
11050 hsa-miR-30c 0.632 1.549
11051 hsa-miR-30d 0.835 1.784
11048 hsa-miR-30a-5p 0.708 1.634
10925 hsa-miR-10b 1.005 2.007
10997 hsa-miR-19a -0.791 -1.730
13173 hsa-miR-17 -0.903 -1.870
11006 hsa-miR-205 -2.216 -4.647
10977 hsa-miR-183 -0.555 -1.469
11031 hsa-miR-26b 0.762 1.695
10968 hsa-miR-17* -0.586 -1.501
10967 hsa-miR-16 -0.665 -1.586
10918 hsa-miR-101 0.549 1.463
10966 hsa-miR-15b -0.708 -1.634
11260 rno-miR-151* 0.638 1.556
11216 mmu-miR-292-5p -0.392 -1.312
11258 rno-miR-140* 0.727 1.655
11224 hsa-miR-30e-3p 0.651 1.570
11009 hsa-miR-20b -0.738 -1.667
10998 hsa-miR-19b -0.698 -1.623
11203 hsa-miR-155_MM1 -0.552 -1.466
11196 hsa-miR-30c_MM2 0.550 1.464
11047 hsa-miR-30a-3p 0.505 1.419
5560 hsa-miR-185 -0.390 -1.310
11200 mmu-miR-129-3p 0.833 1.782
11004 hsa-miR-203 -0.455 -1.371
10990 hsa-miR-196a -0.453 -1.369
11183 hsa-miR-99a 0.951 1.933
13131 hsa-miR-518c* -0.447 -1.363
3320 hsa-let-7a 0.631 1.548
11020 hsa-miR-22 0.506 1.420
11039 hsa-miR-29a 0.470 1.385
10913 hsa-let-7c 0.629 1.546
11067 hsa-miR-338 0.424 1.341
11182 hsa-miR-98 0.338 1.264
10978 hsa-miR-184 -0.371 -1.293
11186 hsa-let-7a_MM2 0.513 1.427
11273 rno-miR-352 0.437 1.354
10938 hsa-miR-133a-133b 0.586 1.501
11199 hsa-miR-106b_MM2 -0.448 -1.365
11064 hsa-miR-331 0.413 1.332
11184 hsa-miR-99b 0.583 1.498
11245 mmu-miR-433-5p -0.357 -1.281
10971 hsa-miR-181a 0.478 1.393
11072 hsa-miR-34a 0.898 1.864
10999 hsa-miR-20a -0.534 -1.448
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11034 hsa-miR-28 0.393 1.313
11002 hsa-miR-200c -0.281 -1.215
11214 mmu-miR-291a-5p -0.378 -1.300
13174 hsa-miR-30e-5p 0.421 1.339
11107 hsa-miR-424 -0.286 -1.220
13150 hsa-miR-424_MM1 -0.313 -1.242
13169 mmu-let-7d* -0.425 -1.343
4500 hsa-let-7g 0.306 1.237
10972 hsa-miR-181b 0.303 1.234
10921 hsa-miR-106a -0.431 -1.348
13141 hsa-miR-18b -0.389 -1.309
10965 hsa-miR-15a -0.323 -1.251
10912 hsa-let-7b 0.237 1.178
10586 hsa-miR-518f*-526a -0.221 -1.165
11175 hsa-miR-525 -0.257 -1.195
10985 hsa-miR-191 0.371 1.293
11235 mmu-miR-351 -0.281 -1.215
10935 hsa-miR-130a 0.256 1.194
11176 hsa-miR-526b -0.264 -1.201
10964 hsa-miR-155 -0.308 -1.238
Page 37 of 53
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support: (434) 817 2040 ext. 167
Aging Cell
For Peer Review
log2 Average Intensity p-value FDR adjusted p-value
8.861 3.81E-17 1.71E-14
11.655 4.72E-15 1.06E-12
10.899 9.34E-14 1.40E-11
11.393 1.53E-13 1.71E-11
8.710 2.86E-12 2.57E-10
9.852 3.46E-12 2.59E-10
12.153 4.72E-12 3.03E-10
9.984 7.00E-12 3.93E-10
11.885 2.88E-11 1.43E-09
11.358 7.74E-11 3.16E-09
9.090 1.40E-10 5.22E-09
9.399 2.31E-10 7.97E-09
9.096 2.49E-10 7.97E-09
11.644 1.12E-09 3.35E-08
10.386 1.96E-09 5.51E-08
8.229 1.10E-08 2.90E-07
10.359 2.58E-08 6.45E-07
9.727 1.09E-07 2.58E-06
10.384 2.48E-07 5.56E-06
9.151 3.39E-07 7.24E-06
13.213 1.65E-06 3.36E-05
8.728 2.43E-06 4.74E-05
9.788 2.68E-06 5.01E-05
8.188 4.55E-06 8.18E-05
9.271 7.96E-06 1.37E-04
9.999 1.02E-05 1.63E-04
11.335 1.00E-05 1.63E-04
9.236 1.19E-05 1.84E-04
12.642 1.23E-05 1.84E-04
8.220 1.65E-05 2.39E-04
9.045 1.87E-05 2.62E-04
8.516 2.59E-05 3.53E-04
7.730 2.98E-05 3.94E-04
11.401 3.28E-05 4.21E-04
13.860 4.28E-05 5.34E-04
10.797 4.50E-05 5.46E-04
13.071 6.30E-05 7.45E-04
13.407 8.35E-05 9.49E-04
8.547 8.67E-05 9.49E-04
11.633 8.66E-05 9.49E-04
11.554 1.15E-04 1.22E-03
9.730 1.56E-04 1.63E-03
10.554 1.99E-04 2.03E-03
8.713 2.04E-04 2.04E-03
8.734 2.30E-04 2.19E-03
9.594 2.29E-04 2.19E-03
8.762 2.55E-04 2.39E-03
12.882 3.44E-04 3.15E-03
8.541 3.97E-04 3.57E-03
9.321 4.48E-04 3.94E-03
9.080 5.37E-04 4.60E-03
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8.711 5.43E-04 4.60E-03
10.953 9.38E-04 7.78E-03
8.862 9.53E-04 7.78E-03
9.632 9.80E-04 7.86E-03
10.217 1.07E-03 8.30E-03
10.310 1.06E-03 8.30E-03
10.745 1.14E-03 8.54E-03
12.233 1.28E-03 9.43E-03
9.306 1.46E-03 1.06E-02
9.015 1.73E-03 1.22E-02
8.597 1.74E-03 1.22E-02
9.488 1.84E-03 1.27E-02
13.329 1.87E-03 1.27E-02
12.167 3.23E-03 2.17E-02
13.182 4.17E-03 2.75E-02
9.016 4.27E-03 2.78E-02
13.929 6.00E-03 3.85E-02
9.843 6.28E-03 3.97E-02
11.352 6.47E-03 4.04E-02
10.420 7.11E-03 4.38E-02
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5740 hsa-miR-21 1.197 2.436 12.155
32789 hsa-miR-92a -1.447 -2.797 9.553
28399 hsa-miR-23a 1.075 2.121 12.859
11027 hsa-miR-23b 0.988 2.006 12.246
11020 hsa-miR-22 1.163 2.364 10.710
4890 hsa-miR-19b -1.030 -2.081 12.623
11030 hsa-miR-26a -0.541 -0.992 13.658
17558 hsa-miR-663 1.432 2.908 8.670
17890 miRPlus_17890 0.855 1.836 10.328
11040 hsa-miR-29b -0.507 -0.961 12.293
11041 hsa-miR-29c -0.686 -1.630 11.262
21472 miRPlus_21472 0.888 1.866 10.766
17565 hsa-miR-30b -0.718 -1.666 12.390
29204 hsa-miR-378 -0.992 -2.011 8.626
19593 hsa-miR-27a 0.907 1.879 11.276
19596 hsa-miR-30d -0.917 -1.908 10.816
17506 hsa-miR-24 0.716 1.649 11.115
27565 hsa-miR-423-5p -0.756 -1.694 11.140
10306 hsa-miR-146b-5p -0.851 -1.808 11.572
11065 hsa-miR-335 -1.504 -2.911 9.417
17502 hsa-miR-30c -0.647 -1.579 12.003
17718 hsa-miR-92b -0.732 -1.671 8.762
17865 miRPlus_17865 -0.971 -1.991 9.689
19602 hsa-let-7g -0.677 -1.601 11.325
31026 hsa-miR-101 -0.668 -1.174 12.043
11052 hsa-miR-31 -1.123 -2.191 9.191
11048 hsa-miR-30a -0.602 -1.525 11.382
10999 hsa-miR-20a -1.168 -2.283 10.490
27533 hsa-miR-320 -1.277 -2.455 9.922
28737 hsa-miR-106a -0.913 -1.887 10.385
11106 hsa-miR-423-3p -0.620 -1.545 9.626
19594 hsa-miR-296-5p 0.747 1.708 9.032
28736 hsa-miR-17 -0.697 -1.628 10.821
10971 hsa-miR-181a -0.615 -1.551 9.342
27544 hsa-miR-363* -0.857 -1.829 9.495
11053 hsa-miR-32 1.015 2.045 9.228
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2.09E-18 1.68E-15
5.84E-18 2.35E-15
1.64E-15 4.41E-13
4.87E-14 9.82E-12
5.22E-12 7.01E-10
4.72E-11 5.44E-09
8.15E-11 8.21E-09
5.89E-10 5.27E-08
7.06E-10 5.69E-08
8.82E-09 5.27E-07
3.54E-08 1.78E-06
9.30E-08 4.41E-06
1.19E-07 5.04E-06
2.05E-07 8.26E-06
2.68E-07 1.03E-05
3.50E-07 1.28E-05
6.68E-07 2.24E-05
1.45E-06 4.69E-05
1.72E-06 5.35E-05
3.07E-06 9.17E-05
4.03E-06 1.16E-04
1.11E-05 2.72E-04
1.09E-05 2.72E-04
1.71E-05 3.95E-04
1.72E-05 3.95E-04
1.84E-05 4.12E-04
1.97E-05 4.19E-04
2.65E-05 5.35E-04
3.99E-05 7.85E-04
3.12E-04 5.84E-03
3.55E-04 6.26E-03
4.07E-04 6.98E-03
4.93E-04 8.28E-03
1.36E-03 2.07E-02
3.24E-03 4.49E-02
3.48E-03 4.67E-02
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11163 hsa-miR-519d -0.855 -1.808 10.856
10997 hsa-miR-19a -0.755 -1.687 10.615
4890 hsa-miR-19b -0.475 -1.390 9.649
11107 hsa-miR-424 -0.472 -1.387 9.598
19592 hsa-miR-212 -0.428 -1.345 10.564
17748 hsa-let-7a -0.356 -1.280 10.874
10999 hsa-miR-20a -0.574 -1.488 8.688
17280 hsa-miR-15b -0.637 -1.555 9.190
27217 hsa-miR-34a 0.448 1.364 9.430
10987 hsa-miR-193b -0.365 -1.288 9.906
28736 hsa-miR-17 -0.619 -1.536 9.032
14293 mmu-miR-546 -0.300 -1.231 10.283
10967 hsa-miR-16 -0.446 -1.362 9.361
21472 miRPlus_21472 0.295 1.227 11.536
11182 hsa-miR-98 -0.374 -1.296 8.903
10914 mmu-let-7d -0.315 -1.244 11.671
13150 mmu-miR-322 -0.618 -1.535 8.274
11201 miRPlus_11201 -0.404 -1.323 9.138
11027 hsa-miR-23b -0.224 -1.168 11.619
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1.49E-10 1.20E-07
8.09E-07 3.26E-04
9.11E-05 2.45E-02
3.33E-04 5.26E-02
3.35E-04 5.26E-02
4.34E-04 5.26E-02
4.57E-04 5.26E-02
8.50E-04 8.56E-02
9.59E-04 8.59E-02
1.95E-03 1.46E-01
2.00E-03 1.46E-01
2.29E-03 1.46E-01
2.35E-03 1.46E-01
3.74E-03 2.16E-01
4.86E-03 2.61E-01
5.20E-03 2.62E-01
6.14E-03 2.91E-01
7.08E-03 3.17E-01
8.12E-03 3.45E-01
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Exiqon Reporter ID (v9.2) Reporter Name log2 Fold Change
11027 hsa-miR-144 2.293
11006 hsa-miR-100 -0.975
11235 hsa-miR-99a -0.997
5740 hsa-miR-199b-5p -1.403
11039 hsa-miR-338-3p -1.384
28232 hsa-miR-451 1.077
11135 hsa-miR-10a -1.066
17832 hsa-miR-519e* 0.917
27554 hsa-miR-335 -1.223
13175 hsa-miR-492 0.879
11020 hsa-miR-125b -0.524
10946 hsa-miR-30d -0.754
11130 hsa-miR-26a -0.463
14287 hsa-miR-130a -0.851
11175 hsa-miR-181a -0.755
11040 hsa-miR-30c -0.817
21757 hsa-miR-326 -0.574
13180 miRPlus_17925 0.912
19593 miRPlus_17952 1.337
4890 mmu-miR-199b* -0.517
19594 mmu-miR-711 0.741
11048 hsa-miR-583 1.039
11030 mmu-miR-351 0.976
31026 mmu-miR-714 1.174
13137 hsa-miR-28-5p -0.691
17915 miRPlus_17945 -0.587
11229 miRPlus_17848 -0.972
4610 hsa-miR-565 -0.933
10934 hsa-miR-184 0.605
17510 hsa-miR-886-3p -1.079
11246 hsa-let-7d -0.430
27566 hsa-let-7g -0.576
30317 hsa-miR-183* 0.868
28431 mmu-miR-300 0.739
hsa-miR-489 -0.510
hsa-miR-152 -0.624
hsa-miR-658 0.728
hsa-miR-374b -0.688
hsa-miR-584 0.495
hsa-miR-191 -0.698
hsa-miR-30e -0.581
hsa-miR-30b* 0.674
hsa-miR-199a-3p/199b-3p -0.734
hsa-miR-376a -0.542
miRPlus_28575 0.610
hsa-miR-200c -0.634
hsa-miR-30b -0.811
hsa-miR-525-5p 1.018
hsa-let-7f -0.610
hsa-miR-486-5p 0.787
hsa-miR-602 0.476
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hsa-miR-96* 0.700
hsa-miR-642 -0.465
hsa-miR-199a-5p -0.443
hsa-miR-342-3p -0.656
miRPlus_27564 0.998
mmu-miR-374 -0.614
hsa-miR-148b -0.552
hsa-miR-199a-3p/199b-3p -0.737
hsa-let-7a -0.657
hsa-miR-196a -0.749
hsa-miR-30e* -0.755
hsa-miR-483-5p 0.942
hsa-miR-99b -0.420
hsa-miR-765 1.119
hsa-miR-10b -0.777
hsa-miR-214 -0.456
hsa-miR-29a 0.383
hsa-miR-381 0.590
hsa-miR-374a -0.647
hsa-miR-675 0.757
hsa-miR-149 -0.614
hsa-miR-126* -0.562
hsa-miR-424 -0.718
mmu-miR-322 -0.755
hsa-miR-107 -0.508
hsa-miR-518d-5p/518f*/520c-5p/526a 0.500
mmu-miR-291b-5p 0.515
hsa-miR-526b 0.587
mmu-miR-320 0.461
mmu-miR-710 0.752
hsa-let-7i -0.299
hsa-miR-101 -0.506
hsa-miR-512-5p 0.334
mmu-let-7a -0.666
hsa-miR-151-5p -0.449
hsa-miR-671-5p 0.545
hsa-miR-126 -0.580
hsa-miR-361-5p -0.413
mmu-miR-330* 0.408
hsa-miR-154* 0.746
hsa-miR-518c* 0.637
hsa-miR-198 0.801
hsa-miR-518a-5p/527 0.470
hsa-miR-15b -0.477
hsa-miR-423-3p 0.420
mmu-miR-666-5p 0.529
hsa-miR-432* 0.455
hsa-miR-494 0.322
hsa-miR-543 0.492
hsa-miR-98 -0.302
hsa-miR-19a -0.407
hsa-miR-210 -0.356
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miRPlus_17921 0.533
miRPlus_17930 0.317
hsa-miR-744 -0.491
hsa-miR-768-5p -0.664
hsa-miR-320 -0.427
hsa-miR-203 -0.444
hsa-miR-376b -0.454
hsa-miR-200b -0.391
mmu-miR-690 -0.476
miRPlus_17957 -0.584
hsa-miR-125a-5p -0.284
hsa-miR-221 -0.446
hsa-miR-371-5p 0.382
hsa-miR-185 0.587
hsa-miR-127-3p -0.520
mmu-let-7d -0.378
mmu-miR-720 0.285
mmu-miR-691 0.428
hsa-miR-212 -0.380
hsa-miR-518e*/519a*/519b-5p/519c-5p/522*/523* 0.536
hsa-miR-146b-5p -0.417
hsa-miR-425* 0.463
mmu-miR-708 -0.476
mmu-miR-709 0.444
hsa-miR-328 -0.331
hsa-miR-196b -0.485
mmu-miR-380-3p 0.584
miRPlus_17865 -0.357
hsa-miR-369-3p 0.919
hsa-miR-886-5p -0.386
hsa-miR-21 0.417
hsa-miR-205 -0.365
hsa-miR-186 -0.440
hsa-miR-365 -0.365
mmu-miR-667 -0.305
mmu-miR-429 -0.418
hsa-miR-222 -0.317
mmu-miR-718 0.393
hsa-miR-15a -0.357
hsa-miR-557 0.404
hsa-miR-625 0.421
mmu-miR-434-3p 0.507
hsa-miR-31 0.723
hsa-miR-429 -0.411
hsa-miR-604 0.471
hsa-miR-490-3p 0.406
hsa-miR-92b -0.356
mmu-miR-298 0.749
hsa-miR-151-3p -0.373
hsa-miR-20a -0.453
hsa-miR-218 -0.686
miRPlus_17833 -0.369
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hsa-miR-498 0.406
hsa-miR-302c* 0.267
hsa-miR-572 -0.330
hsa-let-7a* -0.406
hsa-miR-22 -0.341
miRPlus_17890 0.301
mmu-miR-106a -0.350
hsa-miR-17 -0.475
hsa-miR-20b -0.456
hsa-miR-516b 0.451
miRPlus_28232 -0.289
mmu-miR-298 0.691
hsa-miR-768-3p -0.217
hsa-miR-379 -0.420
hsa-miR-801 0.363
miRPlus_30317 -0.442
hsa-miR-24 -0.192
hsa-miR-27b -0.237
miRPlus_21472 0.304
hsa-miR-566 0.326
hsa-let-7b -0.193
hsa-miR-103 -0.263
mmu-miR-693-5p -0.421
hsa-miR-376c -0.409
hsa-miR-142-5p 0.419
hsa-miR-146a -0.316
hsa-miR-663 0.337
hsa-miR-193b -0.326
mmu-miR-712 0.287
mmu-miR-669a -0.283
hsa-miR-181b -0.345
mmu-miR-34b-5p 0.491
mmu-miR-712* 0.502
hsa-miR-106a -0.355
hsa-miR-141 -0.327
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Fold Change log2 Average Intensity p-value FDR adjusted p-value
4.902 10.847 7.8E-29 6.3E-26
-1.966 10.689 3.2E-19 1.3E-16
-1.996 10.423 1.1E-18 2.9E-16
-2.645 10.490 7.9E-18 1.5E-15
-2.609 9.671 9.1E-18 1.5E-15
2.110 11.897 4.4E-16 5.9E-14
-2.093 10.073 2.3E-15 2.6E-13
1.888 11.515 3.9E-14 3.9E-12
-2.334 8.619 1.7E-13 1.6E-11
1.839 12.380 2.3E-12 1.9E-10
-1.438 12.802 1.8E-11 1.2E-09
-1.687 11.365 1.7E-11 1.2E-09
-1.379 13.306 1.3E-10 7.8E-09
-1.804 10.132 1.8E-10 1.0E-08
-1.687 9.262 2.0E-10 1.0E-08
-1.762 11.496 2.0E-10 1.0E-08
-1.488 11.620 2.8E-10 1.3E-08
1.881 10.088 4.1E-10 1.8E-08
2.527 12.307 4.6E-10 2.0E-08
-1.431 11.189 7.2E-10 2.9E-08
1.671 13.790 8.1E-10 3.1E-08
2.054 10.859 1.1E-09 4.0E-08
1.967 12.863 2.3E-09 8.2E-08
2.257 11.763 2.5E-09 8.5E-08
-1.615 8.836 3.3E-09 1.1E-07
-1.502 9.090 4.3E-09 1.3E-07
-1.962 10.014 9.1E-09 2.7E-07
-1.909 9.665 9.9E-09 2.8E-07
1.521 10.650 1.2E-08 3.1E-07
-2.112 10.789 1.1E-08 3.1E-07
-1.347 12.441 1.2E-08 3.1E-07
-1.490 10.093 1.4E-08 3.5E-07
1.825 11.019 2.7E-08 6.7E-07
1.669 9.768 3.1E-08 7.3E-07
-1.424 10.081 5.8E-08 1.3E-06
-1.541 9.012 9.9E-08 2.2E-06
1.657 10.958 1.2E-07 2.5E-06
-1.611 9.547 1.3E-07 2.7E-06
1.409 9.802 1.4E-07 2.9E-06
-1.622 10.151 1.6E-07 3.2E-06
-1.496 11.264 2.6E-07 5.1E-06
1.595 12.251 4.2E-07 8.1E-06
-1.663 11.418 4.7E-07 8.9E-06
-1.456 8.928 5.2E-07 9.4E-06
1.526 9.912 5.1E-07 9.4E-06
-1.552 11.675 5.8E-07 1.0E-05
-1.755 11.274 5.7E-07 1.0E-05
2.025 12.258 6.3E-07 1.1E-05
-1.526 11.505 7.9E-07 1.3E-05
1.725 8.518 8.0E-07 1.3E-05
1.390 11.593 9.4E-07 1.5E-05
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1.624 9.878 9.8E-07 1.5E-05
-1.380 10.015 1.0E-06 1.6E-05
-1.360 11.294 1.3E-06 1.9E-05
-1.576 8.910 1.3E-06 1.9E-05
1.998 10.797 1.4E-06 2.0E-05
-1.531 10.425 1.5E-06 2.1E-05
-1.467 9.605 1.6E-06 2.2E-05
-1.667 11.356 1.6E-06 2.2E-05
-1.577 13.106 1.7E-06 2.3E-05
-1.681 8.436 1.8E-06 2.4E-05
-1.688 8.702 1.8E-06 2.4E-05
1.922 11.168 1.9E-06 2.4E-05
-1.338 10.628 1.9E-06 2.4E-05
2.172 12.523 2.6E-06 3.2E-05
-1.714 9.123 2.7E-06 3.3E-05
-1.372 10.125 3.6E-06 4.3E-05
1.304 13.115 5.3E-06 6.2E-05
1.505 10.970 5.3E-06 6.2E-05
-1.566 9.543 6.1E-06 7.1E-05
1.690 8.627 7.1E-06 8.0E-05
-1.530 8.005 8.0E-06 9.0E-05
-1.476 9.979 8.2E-06 9.1E-05
-1.645 8.640 9.6E-06 1.0E-04
-1.688 8.651 9.8E-06 1.1E-04
-1.422 10.441 1.1E-05 1.1E-04
1.414 9.952 1.1E-05 1.2E-04
1.429 10.460 1.3E-05 1.3E-04
1.502 9.475 1.3E-05 1.4E-04
1.376 11.784 1.4E-05 1.4E-04
1.685 9.315 1.4E-05 1.4E-04
-1.230 12.071 2.1E-05 2.1E-04
-1.421 12.040 2.2E-05 2.1E-04
1.260 10.959 2.4E-05 2.3E-04
-1.587 13.021 2.8E-05 2.6E-04
-1.366 8.854 2.8E-05 2.6E-04
1.459 11.444 2.9E-05 2.6E-04
-1.494 12.039 2.9E-05 2.6E-04
-1.332 9.661 3.1E-05 2.8E-04
1.327 9.949 3.2E-05 2.9E-04
1.677 9.759 3.4E-05 3.0E-04
1.555 10.871 3.9E-05 3.4E-04
1.743 10.856 4.5E-05 3.9E-04
1.386 11.330 4.8E-05 4.1E-04
-1.392 10.405 4.9E-05 4.1E-04
1.338 11.481 5.3E-05 4.4E-04
1.443 9.688 6.0E-05 4.9E-04
1.371 9.046 7.1E-05 5.8E-04
1.250 13.078 9.1E-05 7.4E-04
1.407 8.895 9.2E-05 7.4E-04
-1.233 12.273 9.1E-05 7.4E-04
-1.326 12.950 9.5E-05 7.5E-04
-1.279 11.523 9.8E-05 7.6E-04
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1.447 10.401 9.7E-05 7.6E-04
1.245 11.471 1.2E-04 9.4E-04
-1.406 7.914 1.3E-04 9.9E-04
-1.585 9.619 1.3E-04 1.0E-03
-1.344 10.560 1.4E-04 1.0E-03
-1.360 12.748 1.7E-04 1.2E-03
-1.370 8.389 1.7E-04 1.2E-03
-1.312 11.718 1.8E-04 1.3E-03
-1.391 9.716 1.8E-04 1.3E-03
-1.499 8.768 1.9E-04 1.4E-03
-1.217 11.964 2.1E-04 1.5E-03
-1.362 11.180 2.4E-04 1.7E-03
1.303 11.098 2.7E-04 1.9E-03
1.502 11.354 2.9E-04 2.0E-03
-1.433 9.540 3.0E-04 2.0E-03
-1.300 13.016 3.0E-04 2.1E-03
1.219 11.093 3.1E-04 2.1E-03
1.345 10.493 3.2E-04 2.2E-03
-1.301 14.192 4.0E-04 2.6E-03
1.450 11.063 4.0E-04 2.6E-03
-1.335 10.249 4.2E-04 2.7E-03
1.378 8.624 4.6E-04 3.0E-03
-1.390 8.186 4.7E-04 3.0E-03
1.360 10.792 4.8E-04 3.0E-03
-1.258 8.819 4.9E-04 3.1E-03
-1.399 8.190 5.0E-04 3.2E-03
1.499 9.094 5.2E-04 3.2E-03
-1.281 10.479 5.6E-04 3.4E-03
1.890 12.179 6.0E-04 3.6E-03
-1.307 9.126 6.0E-04 3.6E-03
1.335 13.766 6.4E-04 3.9E-03
-1.288 13.849 7.0E-04 4.2E-03
-1.357 8.646 7.6E-04 4.5E-03
-1.288 10.401 8.2E-04 4.8E-03
-1.235 11.697 8.5E-04 5.0E-03
-1.336 8.463 8.8E-04 5.1E-03
-1.246 11.230 9.2E-04 5.3E-03
1.313 8.893 9.5E-04 5.4E-03
-1.281 11.130 9.7E-04 5.5E-03
1.323 11.813 9.8E-04 5.5E-03
1.339 8.629 1.1E-03 5.9E-03
1.421 9.261 1.1E-03 6.3E-03
1.651 7.801 1.2E-03 6.5E-03
-1.330 8.740 1.2E-03 6.7E-03
1.386 8.780 1.2E-03 6.7E-03
1.325 8.421 1.3E-03 7.1E-03
-1.280 9.186 1.4E-03 7.5E-03
1.680 10.267 1.5E-03 7.9E-03
-1.295 8.760 1.5E-03 8.0E-03
-1.369 10.470 1.6E-03 8.3E-03
-1.609 7.730 1.7E-03 8.7E-03
-1.292 8.996 1.8E-03 9.5E-03
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1.325 12.603 1.9E-03 9.6E-03
1.203 10.873 1.9E-03 9.9E-03
-1.257 9.504 2.0E-03 1.0E-02
-1.325 8.237 2.1E-03 1.1E-02
-1.266 12.120 2.2E-03 1.1E-02
1.232 12.425 2.2E-03 1.1E-02
-1.275 10.123 2.2E-03 1.1E-02
-1.390 10.702 2.6E-03 1.3E-02
-1.372 8.890 2.6E-03 1.3E-02
1.367 10.746 2.6E-03 1.3E-02
-1.222 11.192 2.6E-03 1.3E-02
1.615 10.262 2.8E-03 1.4E-02
-1.163 12.121 2.9E-03 1.4E-02
-1.338 8.907 2.9E-03 1.4E-02
1.286 10.346 3.0E-03 1.4E-02
-1.358 8.387 3.7E-03 1.8E-02
-1.142 13.110 3.9E-03 1.8E-02
-1.178 13.211 4.0E-03 1.9E-02
1.234 13.439 4.2E-03 1.9E-02
1.254 8.620 4.5E-03 2.1E-02
-1.143 12.762 5.0E-03 2.3E-02
-1.200 10.530 5.1E-03 2.3E-02
-1.339 8.387 5.3E-03 2.4E-02
-1.328 8.233 5.4E-03 2.4E-02
1.337 9.378 5.7E-03 2.6E-02
-1.245 9.577 6.3E-03 2.8E-02
1.263 10.002 6.4E-03 2.8E-02
-1.254 9.716 6.5E-03 2.9E-02
1.220 8.302 6.8E-03 3.0E-02
-1.216 8.800 7.6E-03 3.3E-02
-1.270 7.970 9.1E-03 3.9E-02
1.406 7.458 9.2E-03 4.0E-02
1.416 7.910 1.0E-02 4.3E-02
-1.279 10.647 1.1E-02 4.5E-02
-1.254 11.604 1.2E-02 4.9E-02
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Exiqon Reporter ID (v9.2) Reporter Name log2 Fold Change Fold Change log2 Average Intensity
5740 hsa-miR-21 -2.608 -6.097 12.155
4890 hsa-miR-19b -1.456 -2.743 12.623
28399 hsa-miR-23a 1.246 2.372 12.859
27898 hsa-miR-768-3p 0.863 1.819 14.583
11163 hsa-miR-519d -1.380 -2.603 11.392
28736 hsa-miR-17 -1.438 -2.710 10.821
11040 hsa-miR-29b -1.226 -2.339 12.293
29871 hsa-miR-768-5p 0.817 1.762 13.086
27720 hsa-miR-15a -2.185 -4.548 10.242
21753 hsa-miR-668 1.813 3.514 13.741
13174 hsa-miR-30e -1.934 -3.821 10.910
14285 hsa-miR-487b -1.272 -2.414 9.796
19592 hsa-miR-212 -1.558 -2.945 10.735
19593 hsa-miR-27a -0.936 -1.913 11.276
17752 hsa-let-7f -1.538 -2.904 9.555
32884 hsa-miR-342-3p 0.655 1.575 12.671
19580 hsa-let-7i -0.912 -1.882 10.855
11175 hsa-miR-525-5p -1.373 -2.589 9.014
10997 hsa-miR-19a -0.972 -1.961 11.892
17927 hsa-miR-491-3p -0.887 -1.849 10.146
11027 hsa-miR-23b 0.409 1.328 12.246
11041 hsa-miR-29c -0.505 -1.419 11.262
29872 hsa-miR-340 -0.906 -1.874 9.510
10928 hsa-miR-125a-5p -0.948 -1.929 9.602
11065 hsa-miR-335 -1.249 -2.377 9.417
31809 hsa-miR-590-5p -1.178 -2.263 8.869
11009 hsa-miR-20b -1.098 -2.141 9.220
10306 hsa-miR-146b-5p 0.672 1.594 11.572
13175 hsa-miR-27b -0.551 -1.465 10.898
11130 hsa-miR-498 -0.508 -1.422 9.630
19582 hsa-miR-106b -0.747 -1.678 10.368
11182 hsa-miR-98 -0.831 -1.778 9.027
19004 hsa-let-7c 0.418 1.336 10.890
32883 hsa-miR-801 -0.457 -1.373 10.162
17280 hsa-miR-15b -0.502 -1.417 11.281
13141 hsa-miR-18b -0.721 -1.648 9.298
11007 hsa-miR-206 -0.928 -1.902 8.695
31026 hsa-miR-101 -0.986 -1.981 12.043
10964 hsa-miR-155 -0.730 -1.659 9.886
17869 miRPlus_17869 -0.450 -1.366 10.059
11022 hsa-miR-221 -0.702 -1.626 9.654
18739 hsa-miR-186 -0.804 -1.746 9.433
14287 hsa-miR-494 -0.790 -1.729 8.964
10952 hsa-miR-146a -0.476 -1.391 10.377
11015 hsa-miR-215 -0.471 -1.386 8.703
11053 hsa-miR-32 -0.751 -1.682 9.228
28737 hsa-miR-106a -0.410 -1.329 10.385
11048 hsa-miR-30a -0.302 -1.232 11.382
4700 hsa-miR-140-5p -0.574 -1.489 9.426
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p-value FDR adjusted p-value
2.54E-32 2.05E-29
3.54E-25 1.43E-22
1.54E-22 4.14E-20
3.29E-20 6.64E-18
1.33E-19 2.14E-17
3.45E-19 4.64E-17
2.39E-18 2.75E-16
2.18E-17 2.19E-15
1.30E-15 1.17E-13
7.04E-14 5.67E-12
8.89E-14 6.51E-12
2.00E-13 1.35E-11
4.33E-13 2.68E-11
2.39E-12 1.38E-10
4.15E-12 2.09E-10
5.63E-12 2.67E-10
6.81E-12 3.05E-10
1.30E-11 5.53E-10
3.53E-11 1.42E-09
1.41E-09 4.94E-08
3.03E-08 8.72E-07
1.72E-07 4.47E-06
1.69E-07 4.47E-06
2.97E-07 7.03E-06
5.34E-07 1.20E-05
5.52E-07 1.20E-05
5.93E-07 1.26E-05
9.26E-07 1.87E-05
2.26E-06 4.45E-05
3.63E-06 6.80E-05
7.79E-06 1.43E-04
8.90E-06 1.59E-04
1.06E-05 1.85E-04
2.21E-05 3.79E-04
2.43E-05 4.07E-04
2.90E-05 4.58E-04
2.90E-05 4.58E-04
3.74E-05 5.80E-04
6.89E-05 1.05E-03
8.88E-05 1.32E-03
1.11E-04 1.60E-03
1.54E-04 2.16E-03
2.04E-04 2.79E-03
5.12E-04 6.65E-03
5.78E-04 7.40E-03
1.13E-03 1.43E-02
1.50E-03 1.85E-02
2.71E-03 3.12E-02
4.13E-03 4.69E-02
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